BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,203,246 | -25.2% | 50,031 | -0.7% | 0.00% | – |
| Q2 2023 | $1,608,473 | +3.7% | 50,375 | -0.6% | 0.00% | – |
| Q1 2023 | $1,551,117 | +20.3% | 50,657 | +53.6% | 0.00% | – |
| Q4 2022 | $1,289,496 | -5.8% | 32,971 | +14.7% | 0.00% | – |
| Q3 2022 | $1,369,000 | +39.7% | 28,752 | +13.6% | 0.00% | – |
| Q2 2022 | $980,000 | -23.3% | 25,311 | +13.5% | 0.00% | – |
| Q1 2022 | $1,278,000 | -27.2% | 22,307 | +1.3% | 0.00% | – |
| Q4 2021 | $1,756,000 | -13.5% | 22,030 | -5.6% | 0.00% | -100.0% |
| Q3 2021 | $2,030,000 | -17.3% | 23,335 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $2,456,000 | +200.2% | 19,082 | +86.7% | 0.00% | – |
| Q1 2021 | $818,000 | -94.5% | 10,218 | -94.4% | 0.00% | -100.0% |
| Q4 2020 | $14,909,000 | – | 182,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |